-+ 0.00%
-+ 0.00%
-+ 0.00%

ABCELLERA TO ANNOUNCE TOP-LINE RESULTS FROM THE PHASE 2 TRIAL OF ABCL635 FOR THE TREATMENT OF MODERATE-TO-SEVERE VMS DUE TO MENOPAUSE ON MONDAY, AUGUST 10, 2026

Reuters·08/07/2026 20:30:00

Please log in to view news